Economics of Eye Care

Geographic and Demographic Variation in Use of Ranibizumab Versus Bevacizumab for Neovascular Age-related Macular Degeneration in the United States

December 2017

PURPOSE: To examine demographic and geographic variation in the use of ranibizumab and bevacizumab for the treatment of neovascular age-related macular degeneration (AMD) among Med

Cost-effectiveness of aflibercept, bevacizumab, and ranibizumab for diabetic macular edema treatment analysis from the diabetic retinopathy clinical research network comparative effectiveness trial

June 09, 2016

IMPORTANCE: Anti-vascular endothelial growth factor (VEGF) medicines have revolutionized diabetic macular edema (DME) treatment.

Nidhi Talwar

Chris Andrews, PhD

Leslie M. Niziol, MS

Pages